Elena Nikulina

Revvity tackles hidden TB threat with early testing strategy

Revvity tackles hidden TB threat with early testing strategy
Revvity fights hidden TB threat

Revvity highlights the underestimated prevalence of latent tuberculosis (TB), likening it to an iceberg with most of its impact concealed beneath the surface.

The company asserts that one in four people unknowingly carry the latent form of the disease, which underscores the importance of early testing to prevent its wider spread. By focusing on bridging the gap from risk recognition to prevention, Revvity has accepted the challenge to address this public health concern through proactive measures.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.